These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 18645004

  • 1. Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis.
    Kraus M, Malenke E, Gogel J, Müller H, Rückrich T, Overkleeft H, Ovaa H, Koscielniak E, Hartmann JT, Driessen C.
    Mol Cancer Ther; 2008 Jul; 7(7):1940-8. PubMed ID: 18645004
    [Abstract] [Full Text] [Related]

  • 2. Ritonavir interacts with bortezomib to enhance protein ubiquitination and histone acetylation synergistically in renal cancer cells.
    Sato A, Asano T, Ito K, Asano T.
    Urology; 2012 Apr; 79(4):966.e13-21. PubMed ID: 22296623
    [Abstract] [Full Text] [Related]

  • 3. Caspase-2 functions upstream of mitochondria in endoplasmic reticulum stress-induced apoptosis by bortezomib in human myeloma cells.
    Gu H, Chen X, Gao G, Dong H.
    Mol Cancer Ther; 2008 Aug; 7(8):2298-307. PubMed ID: 18723477
    [Abstract] [Full Text] [Related]

  • 4. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.
    Obeng EA, Carlson LM, Gutman DM, Harrington WJ, Lee KP, Boise LH.
    Blood; 2006 Jun 15; 107(12):4907-16. PubMed ID: 16507771
    [Abstract] [Full Text] [Related]

  • 5. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.
    Nawrocki ST, Carew JS, Dunner K, Boise LH, Chiao PJ, Huang P, Abbruzzese JL, McConkey DJ.
    Cancer Res; 2005 Dec 15; 65(24):11510-9. PubMed ID: 16357160
    [Abstract] [Full Text] [Related]

  • 6. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response.
    Nowis D, McConnell EJ, Dierlam L, Palamarchuk A, Lass A, Wójcik C.
    Int J Cancer; 2007 Jul 15; 121(2):431-41. PubMed ID: 17373661
    [Abstract] [Full Text] [Related]

  • 7. Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis.
    Nawrocki ST, Carew JS, Pino MS, Highshaw RA, Dunner K, Huang P, Abbruzzese JL, McConkey DJ.
    Cancer Res; 2005 Dec 15; 65(24):11658-66. PubMed ID: 16357177
    [Abstract] [Full Text] [Related]

  • 8. Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways.
    Fels DR, Ye J, Segan AT, Kridel SJ, Spiotto M, Olson M, Koong AC, Koumenis C.
    Cancer Res; 2008 Nov 15; 68(22):9323-30. PubMed ID: 19010906
    [Abstract] [Full Text] [Related]

  • 9. Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells.
    Rao R, Nalluri S, Fiskus W, Savoie A, Buckley KM, Ha K, Balusu R, Joshi A, Coothankandaswamy V, Tao J, Sotomayor E, Atadja P, Bhalla KN.
    Clin Cancer Res; 2010 Oct 01; 16(19):4742-54. PubMed ID: 20647473
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.
    Fribley A, Zeng Q, Wang CY.
    Mol Cell Biol; 2004 Nov 01; 24(22):9695-704. PubMed ID: 15509775
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress.
    Ri M, Iida S, Nakashima T, Miyazaki H, Mori F, Ito A, Inagaki A, Kusumoto S, Ishida T, Komatsu H, Shiotsu Y, Ueda R.
    Leukemia; 2010 Aug 01; 24(8):1506-12. PubMed ID: 20555361
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Therapeutic enhancement of ER stress by insulin-like growth factor I sensitizes myeloma cells to proteasomal inhibitors.
    Tagoug I, Jordheim LP, Herveau S, Matera EL, Huber AL, Chettab K, Manié S, Dumontet C.
    Clin Cancer Res; 2013 Jul 01; 19(13):3556-66. PubMed ID: 23674497
    [Abstract] [Full Text] [Related]

  • 17. Calcium channel blocker verapamil enhances endoplasmic reticulum stress and cell death induced by proteasome inhibition in myeloma cells.
    Meister S, Frey B, Lang VR, Gaipl US, Schett G, Schlötzer-Schrehardt U, Voll RE.
    Neoplasia; 2010 Jul 01; 12(7):550-61. PubMed ID: 20651984
    [Abstract] [Full Text] [Related]

  • 18. Bcl-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress.
    Dasmahapatra G, Lembersky D, Rahmani M, Kramer L, Friedberg J, Fisher RI, Dent P, Grant S.
    Cancer Biol Ther; 2009 May 01; 8(9):808-19. PubMed ID: 19270531
    [Abstract] [Full Text] [Related]

  • 19. Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells.
    Sato A, Asano T, Isono M, Ito K, Asano T.
    BMC Urol; 2014 Aug 30; 14():71. PubMed ID: 25176354
    [Abstract] [Full Text] [Related]

  • 20. Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.
    Meister S, Schubert U, Neubert K, Herrmann K, Burger R, Gramatzki M, Hahn S, Schreiber S, Wilhelm S, Herrmann M, Jäck HM, Voll RE.
    Cancer Res; 2007 Feb 15; 67(4):1783-92. PubMed ID: 17308121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.